Oxidative Phosphorylation in Silent Pituitary Adenomas: A Multiomics Perspective
International Journal of Endocrinology, Volume 2026, Issue 1, 2026.Although the World Health Organization has clearly defined silent pituitary adenomas (SPAs) and functional adenomas (non‐SPAs), the detailed biological mechanisms remain unclear. This study conducted a comprehensive analysis of clinical, genomic, transcriptomic, and proteomic differences between SPA and non‐SPA.
Yuan Chen +5 more
wiley +1 more source
Differential Distribution of erbB Receptors in Human Glioblastoma Multiforme: Expression of erbB3 in CD133-Positive Putative Cancer Stem Cells: Erratum [PDF]
, 2010 openalex +1 more source
Mediators of Inflammation, Volume 2026, Issue 1, 2026.Background Wilson’s disease (WD), caused by mutations in the ATP7B gene, leads to copper accumulation and multi‐organ damage. Exosomal microRNAs (miRNAs) play a crucial role in cell‐to‐cell communication and the pathogenesis of diseases, yet their study in WD remains unreported.
Hong Chen +6 more
wiley +1 more source
Inhibition of pancreatic carcinoma by homo- and heterocombinations of antibodies against EGF-receptor and its kin HER2/ErbB-2 [PDF]
, 2013 Ruth Maron +5 more
openalex +1 more source
Uterine Serous Carcinoma Arising From Endometrial Polyp: A Case Report
Gynecology Obstetrics & Reproductive Medicine, 2009 Serous carcinoma is the prototype of type II endometrial carcinoma. A 71-year-old woman who had history of smoking, diabetes mellitus and hypertension admitted to the hospital with postmenopausal uterine bleeding.
Sibel Bektaş +4 more
doaj
Direct and immune mediated antibody targeting of ERBB receptors in a colorectal cancer cell-line panel [PDF]
, 2012 Shazad Q. Ashraf +5 more
openalex +1 more source
Spinal nerve injury causes upregulation of ErbB2 and ErbB3 receptors in rat dorsal root ganglia
Journal of Pain Research, 2013 Satoshi Mizobuchi,1* Hirotaka Kanzaki,1–3* Hiroki Omiya,1 Yoshikazu Matsuoka,1 Norihiko Obata,1 Ryuji Kaku,1 Hirochika Nakajima,1 Mamoru Ouchida,2 Kiyoshi Morita11Department of Anesthesiology and Resuscitology, 2Department of Molecular Genetics,
Mizobuchi S +8 more
doaj
A Phase I-II Study of Combined Blockade of the ErbB Receptor Network with Trastuzumab and Gefitinib in Patients with HER2 (ErbB2)-Overexpressing Metastatic Breast Cancer [PDF]
, 2008 Carlos L. Arteaga +6 more
openalex +1 more source
ErbB-Inhibitory Protein: A Modified Ectodomain of Epidermal Growth Factor Receptor Synergizes with Dasatinib to Inhibit Growth of Breast Cancer Cells [PDF]
, 2010 Jyoti Nautiyal +10 more
openalex +1 more source